Literature DB >> 23602127

Results of elective repair at 6 months or younger in 277 patients with tetralogy of Fallot: a 14-year experience at a single center.

Roxanne E Kirsch1, Andrew C Glatz2, J William Gaynor3, Susan C Nicolson4, Thomas L Spray3, Gil Wernovsky5, Geoffrey L Bird5.   

Abstract

OBJECTIVE: To report practice and outcomes in infants undergoing elective repair of tetralogy of Fallot.
METHODS: A review of a retrospective cohort of elective complete repair of infants age 6 months or younger from 1995 to 2009 was performed. Patients were excluded because of previous interventions, hypercyanotic episodes, intensive care admissions, additional major cardiac defects, or if they were not discharged after birth. Length of stay, mortality, and complications were recorded. Association was determined using logistic or linear regression models and univariate testing determined the multivariate model.
RESULTS: There were 277 patients included. The hospital mortality rate was zero. A total of 87.4% of patients were discharged home within 7 days of repair, and 21.6% of patients were discharged on or before the third postoperative day. The postoperative course was uncomplicated in 245 patients (88.4%). Longer support time was associated independently with increased odds of complications (P < .001). Longer support time, younger age, chromosomal abnormality, and presence of a complication were associated independently with a longer hospital stay (all P < .001). Patients younger than 3 months (n = 110) had a longer median hospital stay (4 vs 3 days; P < .001) and longer support times (77.3 ± 35.1 min vs 66.4 ± 34 min; P < .01).
CONCLUSIONS: Elective tetralogy of Fallot repair was performed at 6 months or younger with low morbidity, no hospital mortality, and an 11.6% complication rate. Longer support times, lower weight, chromosomal abnormalities, and complications were associated with a significantly increased duration of hospital stay.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  20; 41.1; ACC; CPB; DHCA; LOS; LSCA; RAA; TOF; TST; aortic cross-clamp; cardiopulmonary bypass; deep hypothermic circulatory arrest; left subclavian artery; length of stay; right aortic arch; tetralogy of Fallot; total support time

Mesh:

Year:  2013        PMID: 23602127     DOI: 10.1016/j.jtcvs.2013.03.033

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  2-Year Outcomes After Complete or Staged Procedure for Tetralogy of Fallot in Neonates.

Authors:  Jill J Savla; Jennifer A Faerber; Yuan-Shung V Huang; Theoklis Zaoutis; Elizabeth Goldmuntz; Steven M Kawut; Laura Mercer-Rosa
Journal:  J Am Coll Cardiol       Date:  2019-09-24       Impact factor: 24.094

2.  Effect of Weight Extremes on Ventricular Volumes and Myocardial Strain in Repaired Tetralogy of Fallot as Measured by CMR.

Authors:  Scott A Simpson; Suzanne L Field; Meng Xu; Benjamin R Saville; David A Parra; Jonathan H Soslow
Journal:  Pediatr Cardiol       Date:  2017-12-14       Impact factor: 1.655

3.  High CpG island methylation of p16 gene and loss of p16 protein expression associate with the development and progression of tetralogy of Fallot.

Authors:  Si-Ju Gao; Gui-Fang Zhang; Rong-Peng Zhang
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

4.  Conal Septal Hypoplasia in Tetralogy of Fallot-Impact on Clinical Course, Treatment Strategies, and Outcomes After Surgical Intervention.

Authors:  Kirsten E Borsheim; Ronald K Woods; Evelyn M Kuhn; Peter C Frommelt
Journal:  Pediatr Cardiol       Date:  2022-07-19       Impact factor: 1.838

5.  Intramural Ventricular Septal Defect Is a Distinct Clinical Entity Associated With Postoperative Morbidity in Children After Repair of Conotruncal Anomalies.

Authors:  Jyoti K Patel; Andrew C Glatz; Reena M Ghosh; Shannon M Jones; Shobha Natarajan; Chitra Ravishankar; Christopher E Mascio; Thomas L Spray; Meryl S Cohen
Journal:  Circulation       Date:  2015-08-05       Impact factor: 29.690

6.  Predictors of a complicated course after surgical repair of tetralogy of Fallot.

Authors:  Servet Ergün; Serhat Bahadır Genç; Okan Yıldız; Erkut Öztürk; Mustafa Güneş; İsmihan Selen Onan; Alper Güzeltaş; Sertaç Haydin
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

7.  Comparison of Management Strategies for Neonates With Symptomatic Tetralogy of Fallot.

Authors:  Bryan H Goldstein; Christopher J Petit; Athar M Qureshi; Courtney E McCracken; Michael S Kelleman; George T Nicholson; Mark A Law; Jeffery J Meadows; Jeffrey D Zampi; Shabana Shahanavaz; Christopher E Mascio; Paul J Chai; Jennifer C Romano; Sarosh P Batlivala; Shiraz A Maskatia; Ivor B Asztalos; Alicia M Kamsheh; Steven J Healan; Justin D Smith; R Allen Ligon; Joelle A Pettus; Sarina Juma; James E B Raulston; Krissie M Hock; Amy L Pajk; Lindsay F Eilers; Hala Q Khan; Taylor C Merritt; Matthew Canter; Stephan Juergensen; Fatuma-Ayaan Rinderknecht; Holly Bauser-Heaton; Andrew C Glatz
Journal:  J Am Coll Cardiol       Date:  2021-03-02       Impact factor: 24.094

Review 8.  When is the Best Time for Corrective Surgery in Patients with Tetralogy of Fallot between 0 and 12 Months of Age?

Authors:  Izabela F Martins; Iara C Doles; Nathalie J M Bravo-Valenzuela; Adriana O R Dos Santos; Marcela S P Varella
Journal:  Braz J Cardiovasc Surg       Date:  2018 Sep-Oct

9.  Impact of timing on in-patient outcomes of complete repair of tetralogy of Fallot in infancy: an analysis of the United States National Inpatient 2005-2011 database.

Authors:  Shihai Yang; Linlin Wen; Shuguang Tao; Jiangrong Gu; Jiangang Han; Junping Yao; Jianming Wang
Journal:  BMC Cardiovasc Disord       Date:  2019-02-26       Impact factor: 2.298

10.  Predictors of Length of Hospital Stay After Complete Repair for Tetralogy of Fallot: A Prospective Cohort Study.

Authors:  Laura Mercer-Rosa; Okan U Elci; Grace DeCost; Stacy Woyciechowski; Sharon M Edman; Chitra Ravishankar; Christopher E Mascio; Steven M Kawut; Elizabeth Goldmuntz
Journal:  J Am Heart Assoc       Date:  2018-05-16       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.